News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines in the past hour; trading remained quiet across equities and bonds.
  • No new central bank comments or economic data released to alter near-term rate expectations.
  • Energy and commodity prices lacked fresh catalysts and traded in narrow ranges.
  • No significant geopolitical incidents or corporate earnings announcements reported during the hour.
  • The dollar and core sovereign yields were steady absent fresh drivers.
  • Market participants remained positioned for scheduled events later today to provide direction.

Latest Articles

Microchip Introduces its First Turnkey Touch Controllers for Buttons, Sliders and Wheels with Parallel Sensing

Microchip Introduces its First Turnkey Touch Controllers for Buttons, Sliders and Wheels with Parallel Sensing

Microchip Technology has introduced its first turnkey capacitive-touch controllers featuring parallel sensing, the MTCH3380P and MTCH3240P, designed to support multiple buttons, sliders, and wheels simultaneously. These controllers offer improved signal-to-noise ratio and faster touch acquisition, helping manufacturers create cost-effective, displa…

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution

Tilray Brands delivered record first-quarter fiscal 2027 results with net revenue of $257 million, up 23% year-over-year, and gross profit of $77.5 million, up 35%. Growth was led by a 71% increase in EMEA revenue and an 82% increase in beverage net revenue, including the acquisition of BrewDog. Tilray maintained a strong balance sheet with a net c…

Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia

Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia

Cullinan Therapeutics has dosed the first patient in its registrational Phase 2 study of CLN-049, a novel FLT3 T cell engager, targeting relapsed/refractory acute myeloid leukemia (AML). The study follows FDA feedback and aims to assess safety and efficacy in AML patients, including those with high-risk TP53 mutations. CLN-049 is also being studied…

Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia

Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia

Editas Medicine announced it has obtained approval to initiate a Phase 1/2 clinical trial of EDIT-401, an experimental in vivo gene editing therapy targeting LDL cholesterol reduction, in patients with heterozygous familial hypercholesterolemia (HeFH) in Australia, with submissions underway in New Zealand. The company expects to begin patient dosin…

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

Gain Therapeutics, a clinical-stage biotech company developing next-generation allosteric therapies, announced its participation in the 2026 Maxim Growth Summit. The event provides Gain the opportunity to meet institutional investors and analysts to discuss its pipeline, including its lead drug candidate rexaceract, currently in Phase 1b trials for…

Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology

Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology

Nutriband Inc. has filed a new non-provisional utility patent application with the USPTO aimed at strengthening intellectual property protection for its AVERSA™ transdermal abuse deterrent technology. The technology is designed to prevent misuse and accidental exposure of opioid and stimulant drugs through an aversive agent coating on transdermal p…

SunPower-REC Introduce Monolith II Solar Panel

SunPower-REC Introduce Monolith II Solar Panel

SunPower Inc., a US-based solar technology and installation company, announced the introduction of Monolith II, a next-generation premium high-wattage solar panel developed with REC. This new bifacial panel produces 522 watts, improving on their previous Monolith model and designed to maximize annual energy output and economic returns for customers…

Aspire To Unveil Command Center at Ignite 2026, Bringing AI-Powered Insights and Action Together for Landscape Contractors

Aspire To Unveil Command Center at Ignite 2026, Bringing AI-Powered Insights and Action Together for Landscape Contractors

Aspire Software, a subsidiary of ServiceTitan, announced the upcoming launch of Command Center at Ignite 2026, an AI-driven intelligence platform providing landscape contractors near real-time operational insights. The new tool integrates Aspire’s business data with AI conversational agent Atlas to offer customizable dashboards, alerts, and analyti…

Auddia Posts CEO Letter to Shareholders Highlighting LT350 Momentum, Strategic Partnerships, and AI Infrastructure Opportunity

Auddia Posts CEO Letter to Shareholders Highlighting LT350 Momentum, Strategic Partnerships, and AI Infrastructure Opportunity

Auddia Inc. (NASDAQ: AUUD) posted a CEO letter updating shareholders on the progress of its proposed merger with Thramann Holdings to form McCarthy Finney, an AI-native company. The letter highlights LT350, a patented distributed AI datacenter platform deploying solar canopy datacenters over parking lots, addressing traditional datacenter expansion…

A Partnership for Pets: Simon Cowell and Trupanion Team Up

A Partnership for Pets: Simon Cowell and Trupanion Team Up

Trupanion, a leading pet insurance company listed on NASDAQ as TRUP, announced a new partnership with television personality Simon Cowell to increase awareness about the importance of pet insurance. Cowell, who insured his four dogs with Trupanion, will collaborate with the company on media initiatives to educate pet owners on managing veterinary c…

What Actually Keeps Weight Off After a Weight Loss Program

What Actually Keeps Weight Off After a Weight Loss Program

Medifast, Inc. highlights the effectiveness of its Trilivy metabolic health system in preserving lean mass and reducing visceral fat, key factors in maintaining weight loss long term. The program combines structured nutrition, personalized coaching, and habit formation to support metabolic health beyond initial weight loss phases, as supported by c…

Beamr to Present at the ThinkEquity Conference: Advancing from Validation towards Commercialization in the Autonomous Vehicle Market

Beamr to Present at the ThinkEquity Conference: Advancing from Validation towards Commercialization in the Autonomous Vehicle Market

Beamr Imaging Ltd. announced its presentation at the ThinkEquity Conference highlighting progress from technology validation to commercialization in the autonomous vehicle market. The company reported strategic milestones, inclusion in Intempora's RTMaps AI Store, renewal of a three-year license with a major streaming platform, and a forecasted 50%…

Heritage Insurance: Cheap, Cash-Rich, and Riding Better Underwriting

Heritage Insurance: Cheap, Cash-Rich, and Riding Better Underwriting

Heritage Insurance (HRTG) looks attractively priced at about $34.55 with a P/E under 5, EV/EBITDA ~1.68 and implied net cash on the balance sheet. Underwriting discipline has driven profitability higher and free cash flow is large relative to market cap. This trade idea lays out an entry, stop and target along with catalysts and risks for a mid-to-…